The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemostatic and Tissue Sealing Agents Market Research Report 2025
Synopsis
Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
The global Hemostatic and Tissue Sealing Agents market was valued at US$ 2801.8 million in 2023 and is anticipated to reach US$ 3454.4 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostatic and Tissue Sealing Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic and Tissue Sealing Agents.
Report Scope
The Hemostatic and Tissue Sealing Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic and Tissue Sealing Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic and Tissue Sealing Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
Segment by Type
Hemostatic
Sealant Gum
Segment by Application
Minimally Invasive Surgery
General Surgery
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
The global Hemostatic and Tissue Sealing Agents market was valued at US$ 2801.8 million in 2023 and is anticipated to reach US$ 3454.4 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostatic and Tissue Sealing Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic and Tissue Sealing Agents.
Report Scope
The Hemostatic and Tissue Sealing Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic and Tissue Sealing Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic and Tissue Sealing Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
Segment by Type
Hemostatic
Sealant Gum
Segment by Application
Minimally Invasive Surgery
General Surgery
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemostatic and Tissue Sealing Agents Market Overview
1.1 Product Overview and Scope of Hemostatic and Tissue Sealing Agents
1.2 Hemostatic and Tissue Sealing Agents Segment by Type
1.2.1 Global Hemostatic and Tissue Sealing Agents Market Value Comparison by Type (2024-2030)
1.2.2 Hemostatic
1.2.3 Sealant Gum
1.3 Hemostatic and Tissue Sealing Agents Segment by Application
1.3.1 Global Hemostatic and Tissue Sealing Agents Market Value by Application: (2024-2030)
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Other
1.4 Global Hemostatic and Tissue Sealing Agents Market Size Estimates and Forecasts
1.4.1 Global Hemostatic and Tissue Sealing Agents Revenue 2019-2030
1.4.2 Global Hemostatic and Tissue Sealing Agents Sales 2019-2030
1.4.3 Global Hemostatic and Tissue Sealing Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostatic and Tissue Sealing Agents Market Competition by Manufacturers
2.1 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostatic and Tissue Sealing Agents Average Price by Manufacturers (2019-2024)
2.4 Global Hemostatic and Tissue Sealing Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Product Type & Application
2.7 Hemostatic and Tissue Sealing Agents Market Competitive Situation and Trends
2.7.1 Hemostatic and Tissue Sealing Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostatic and Tissue Sealing Agents Players Market Share by Revenue
2.7.3 Global Hemostatic and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostatic and Tissue Sealing Agents Retrospective Market Scenario by Region
3.1 Global Hemostatic and Tissue Sealing Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostatic and Tissue Sealing Agents Global Hemostatic and Tissue Sealing Agents Sales by Region: 2019-2030
3.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2019-2024
3.2.2 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2025-2030
3.3 Global Hemostatic and Tissue Sealing Agents Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2019-2030
3.3.1 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2019-2024
3.3.2 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2025-2030
3.4 North America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.4.1 North America Hemostatic and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostatic and Tissue Sealing Agents Sales by Country (2019-2030)
3.4.3 North America Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.5.1 Europe Hemostatic and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostatic and Tissue Sealing Agents Sales by Country (2019-2030)
3.5.3 Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostatic and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.7.1 Latin America Hemostatic and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2019-2030)
3.7.3 Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2019-2030)
4.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2019-2024)
4.1.2 Global Hemostatic and Tissue Sealing Agents Sales by Type (2025-2030)
4.1.3 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2019-2030)
4.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2019-2030)
4.2.1 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2019-2024)
4.2.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2025-2030)
4.2.3 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2019-2030)
4.3 Global Hemostatic and Tissue Sealing Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2019-2030)
5.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2019-2024)
5.1.2 Global Hemostatic and Tissue Sealing Agents Sales by Application (2025-2030)
5.1.3 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2019-2030)
5.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2019-2030)
5.2.1 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2019-2024)
5.2.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2025-2030)
5.2.3 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2019-2030)
5.3 Global Hemostatic and Tissue Sealing Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 J&J
6.1.1 J&J Corporation Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 J&J Hemostatic and Tissue Sealing Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Hemostatic and Tissue Sealing Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 C R Bard
6.3.1 C R Bard Corporation Information
6.3.2 C R Bard Description and Business Overview
6.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 C R Bard Hemostatic and Tissue Sealing Agents Product Portfolio
6.3.5 C R Bard Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Corporation Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B Braun Hemostatic and Tissue Sealing Agents Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 Integra Life Sciences
6.5.1 Integra Life Sciences Corporation Information
6.5.2 Integra Life Sciences Description and Business Overview
6.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolio
6.5.5 Integra Life Sciences Recent Developments/Updates
6.6 Advance Medical Solution
6.6.1 Advance Medical Solution Corporation Information
6.6.2 Advance Medical Solution Description and Business Overview
6.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolio
6.6.5 Advance Medical Solution Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 CryoLife
6.8.1 CryoLife Corporation Information
6.8.2 CryoLife Description and Business Overview
6.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CryoLife Hemostatic and Tissue Sealing Agents Product Portfolio
6.8.5 CryoLife Recent Developments/Updates
6.9 Zimmer Biomet
6.9.1 Zimmer Biomet Corporation Information
6.9.2 Zimmer Biomet Description and Business Overview
6.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolio
6.9.5 Zimmer Biomet Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Hemostatic and Tissue Sealing Agents Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Medtronic
6.11.1 Medtronic Corporation Information
6.11.2 Medtronic Hemostatic and Tissue Sealing Agents Description and Business Overview
6.11.3 Medtronic Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Medtronic Hemostatic and Tissue Sealing Agents Product Portfolio
6.11.5 Medtronic Recent Developments/Updates
6.12 Smith & Nephew
6.12.1 Smith & Nephew Corporation Information
6.12.2 Smith & Nephew Hemostatic and Tissue Sealing Agents Description and Business Overview
6.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolio
6.12.5 Smith & Nephew Recent Developments/Updates
6.13 Cohera Medical
6.13.1 Cohera Medical Corporation Information
6.13.2 Cohera Medical Hemostatic and Tissue Sealing Agents Description and Business Overview
6.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolio
6.13.5 Cohera Medical Recent Developments/Updates
6.14 Shanghai Haohai Biological Technology Co. Ltd.
6.14.1 Shanghai Haohai Biological Technology Co. Ltd. Corporation Information
6.14.2 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Description and Business Overview
6.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolio
6.14.5 Shanghai Haohai Biological Technology Co. Ltd. Recent Developments/Updates
6.15 Shandong Saikesaisi Biotechnology Co., Ltd
6.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Corporation Information
6.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Description and Business Overview
6.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolio
6.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments/Updates
6.16 Chang ShaHai Run biological technology Co, LTD
6.16.1 Chang ShaHai Run biological technology Co, LTD Corporation Information
6.16.2 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Description and Business Overview
6.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolio
6.16.5 Chang ShaHai Run biological technology Co, LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic and Tissue Sealing Agents Industry Chain Analysis
7.2 Hemostatic and Tissue Sealing Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic and Tissue Sealing Agents Production Mode & Process
7.4 Hemostatic and Tissue Sealing Agents Sales and Marketing
7.4.1 Hemostatic and Tissue Sealing Agents Sales Channels
7.4.2 Hemostatic and Tissue Sealing Agents Distributors
7.5 Hemostatic and Tissue Sealing Agents Customers
8 Hemostatic and Tissue Sealing Agents Market Dynamics
8.1 Hemostatic and Tissue Sealing Agents Industry Trends
8.2 Hemostatic and Tissue Sealing Agents Market Drivers
8.3 Hemostatic and Tissue Sealing Agents Market Challenges
8.4 Hemostatic and Tissue Sealing Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hemostatic and Tissue Sealing Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hemostatic and Tissue Sealing Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hemostatic and Tissue Sealing Agents Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hemostatic and Tissue Sealing Agents Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hemostatic and Tissue Sealing Agents Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hemostatic and Tissue Sealing Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Product Type & Application
Table 12. Global Key Manufacturers of Hemostatic and Tissue Sealing Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemostatic and Tissue Sealing Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic and Tissue Sealing Agents as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemostatic and Tissue Sealing Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hemostatic and Tissue Sealing Agents Sales by Region (2019-2024) & (K Units)
Table 18. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2019-2024)
Table 19. Global Hemostatic and Tissue Sealing Agents Sales by Region (2025-2030) & (K Units)
Table 20. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2025-2030)
Table 21. Global Hemostatic and Tissue Sealing Agents Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2019-2024)
Table 23. Global Hemostatic and Tissue Sealing Agents Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2025-2030)
Table 25. North America Hemostatic and Tissue Sealing Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hemostatic and Tissue Sealing Agents Sales by Country (2019-2024) & (K Units)
Table 27. North America Hemostatic and Tissue Sealing Agents Sales by Country (2025-2030) & (K Units)
Table 28. North America Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hemostatic and Tissue Sealing Agents Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hemostatic and Tissue Sealing Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hemostatic and Tissue Sealing Agents Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hemostatic and Tissue Sealing Agents Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hemostatic and Tissue Sealing Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Type (2019-2024)
Table 51. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Type (2025-2030)
Table 52. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2019-2024)
Table 53. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2025-2030)
Table 54. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2019-2024)
Table 57. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2025-2030)
Table 58. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2019-2024)
Table 59. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2025-2030)
Table 60. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Application (2019-2024)
Table 61. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Application (2025-2030)
Table 62. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2019-2024)
Table 63. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2025-2030)
Table 64. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2019-2024)
Table 67. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2025-2030)
Table 68. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2019-2024)
Table 69. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2025-2030)
Table 70. J&J Corporation Information
Table 71. J&J Description and Business Overview
Table 72. J&J Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. J&J Hemostatic and Tissue Sealing Agents Product
Table 74. J&J Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Baxter Hemostatic and Tissue Sealing Agents Product
Table 79. Baxter Recent Developments/Updates
Table 80. C R Bard Corporation Information
Table 81. C R Bard Description and Business Overview
Table 82. C R Bard Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. C R Bard Hemostatic and Tissue Sealing Agents Product
Table 84. C R Bard Recent Developments/Updates
Table 85. B Braun Corporation Information
Table 86. B Braun Description and Business Overview
Table 87. B Braun Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. B Braun Hemostatic and Tissue Sealing Agents Product
Table 89. B Braun Recent Developments/Updates
Table 90. Integra Life Sciences Corporation Information
Table 91. Integra Life Sciences Description and Business Overview
Table 92. Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Integra Life Sciences Hemostatic and Tissue Sealing Agents Product
Table 94. Integra Life Sciences Recent Developments/Updates
Table 95. Advance Medical Solution Corporation Information
Table 96. Advance Medical Solution Description and Business Overview
Table 97. Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Advance Medical Solution Hemostatic and Tissue Sealing Agents Product
Table 99. Advance Medical Solution Recent Developments/Updates
Table 100. CSL Behring Corporation Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. CSL Behring Hemostatic and Tissue Sealing Agents Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. CryoLife Corporation Information
Table 106. CryoLife Description and Business Overview
Table 107. CryoLife Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CryoLife Hemostatic and Tissue Sealing Agents Product
Table 109. CryoLife Recent Developments/Updates
Table 110. Zimmer Biomet Corporation Information
Table 111. Zimmer Biomet Description and Business Overview
Table 112. Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zimmer Biomet Hemostatic and Tissue Sealing Agents Product
Table 114. Zimmer Biomet Recent Developments/Updates
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Pfizer Hemostatic and Tissue Sealing Agents Product
Table 119. Pfizer Recent Developments/Updates
Table 120. Medtronic Corporation Information
Table 121. Medtronic Description and Business Overview
Table 122. Medtronic Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Medtronic Hemostatic and Tissue Sealing Agents Product
Table 124. Medtronic Recent Developments/Updates
Table 125. Smith & Nephew Corporation Information
Table 126. Smith & Nephew Description and Business Overview
Table 127. Smith & Nephew Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Smith & Nephew Hemostatic and Tissue Sealing Agents Product
Table 129. Smith & Nephew Recent Developments/Updates
Table 130. Cohera Medical Corporation Information
Table 131. Cohera Medical Description and Business Overview
Table 132. Cohera Medical Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Cohera Medical Hemostatic and Tissue Sealing Agents Product
Table 134. Cohera Medical Recent Developments/Updates
Table 135. Shanghai Haohai Biological Technology Co. Ltd. Corporation Information
Table 136. Shanghai Haohai Biological Technology Co. Ltd. Description and Business Overview
Table 137. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product
Table 139. Shanghai Haohai Biological Technology Co. Ltd. Recent Developments/Updates
Table 140. Shandong Saikesaisi Biotechnology Co., Ltd Corporation Information
Table 141. Shandong Saikesaisi Biotechnology Co., Ltd Description and Business Overview
Table 142. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product
Table 144. Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments/Updates
Table 145. Chang ShaHai Run biological technology Co, LTD Corporation Information
Table 146. Chang ShaHai Run biological technology Co, LTD Description and Business Overview
Table 147. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product
Table 149. Chang ShaHai Run biological technology Co, LTD Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Hemostatic and Tissue Sealing Agents Distributors List
Table 153. Hemostatic and Tissue Sealing Agents Customers List
Table 154. Hemostatic and Tissue Sealing Agents Market Trends
Table 155. Hemostatic and Tissue Sealing Agents Market Drivers
Table 156. Hemostatic and Tissue Sealing Agents Market Challenges
Table 157. Hemostatic and Tissue Sealing Agents Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hemostatic and Tissue Sealing Agents
Figure 2. Global Hemostatic and Tissue Sealing Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hemostatic and Tissue Sealing Agents Market Share by Type in 2023 & 2030
Figure 4. Hemostatic Product Picture
Figure 5. Sealant Gum Product Picture
Figure 6. Global Hemostatic and Tissue Sealing Agents Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hemostatic and Tissue Sealing Agents Market Share by Application in 2023 & 2030
Figure 8. Minimally Invasive Surgery
Figure 9. General Surgery
Figure 10. Other
Figure 11. Global Hemostatic and Tissue Sealing Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Hemostatic and Tissue Sealing Agents Market Size (2019-2030) & (US$ Million)
Figure 13. Global Hemostatic and Tissue Sealing Agents Sales (2019-2030) & (K Units)
Figure 14. Global Hemostatic and Tissue Sealing Agents Average Price (US$/Unit) & (2019-2030)
Figure 15. Hemostatic and Tissue Sealing Agents Report Years Considered
Figure 16. Hemostatic and Tissue Sealing Agents Sales Share by Manufacturers in 2023
Figure 17. Global Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Hemostatic and Tissue Sealing Agents Players: Market Share by Revenue in 2023
Figure 19. Hemostatic and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Hemostatic and Tissue Sealing Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2019-2030)
Figure 22. North America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2019-2030)
Figure 26. Europe Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2019-2030)
Figure 27. Germany Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2019-2030)
Figure 34. China Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2019-2030)
Figure 44. Latin America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Hemostatic and Tissue Sealing Agents by Type (2019-2030)
Figure 54. Global Revenue Market Share of Hemostatic and Tissue Sealing Agents by Type (2019-2030)
Figure 55. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Hemostatic and Tissue Sealing Agents by Application (2019-2030)
Figure 57. Global Revenue Market Share of Hemostatic and Tissue Sealing Agents by Application (2019-2030)
Figure 58. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2019-2030)
Figure 59. Hemostatic and Tissue Sealing Agents Value Chain
Figure 60. Hemostatic and Tissue Sealing Agents Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
